Abstract:
Neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and Huntington’s diseases as well as amyotrophic lateral sclerosis, are a heterogeneous group of clinical diseases that are characterized by the selective loss of neurons in specific regions of the CNS. Despite their variability they have similar features including the accumulation of misfolded proteins that eventually develop into inclusion bodies. Whether these protein deposits are pathogenic or represent a coping mechanism to prolong survival of the affected neurons is a hotly debated issue. One important point to consider is that these protein deposits are indicative of a disease-state as they are not prevalent in healthy cells. Ubiquitinated proteins are major components of these proteinaceous cytoplasmic or nuclear inclusions suggesting that impaired proteasome activity and the ubiquitination machinery may be main players in this process. Emerging data revealed that autophagosomes are also components of inclusion bodies, implicating the autophagy/lysosome pathway in neurodegenerative disorders as well. Herein, we compare some of the most important characteristics of these two pathways for intracellular protein degradation and discuss their potential role in neurodegeneration. When the proteasome is impaired, it is possible that autophagy may be the alternate pathway for clearing out aggregated ubiquitinated proteins. The question emerges if this potential “survival” mechanism can be explored as a strategy to overcome the most common feature shared by various neurodegenerative disorders, i.e., protein aggregation manifested as inclusion bodies. One potential drawback is that degradation through autophagy seems to be a “bulky,” nonspecific process. A thorough knowledge of the mechanisms involved in the targeting of substrates to autophagy will provide clues to the putative specificity of this pathway so that its ectopic manipulation will target only abnormal protein aggregates and not critical intracellular components, the removal of which may cause cell death.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Alzheimer’s disease
- ALS:
-
amyotrophic lateral sclerosis
- ALP:
-
autophagy/lysosome pathway
- Atg:
-
autophagy related genes
- CMA:
-
chaperone-mediated autophagy
- E1:
-
ubiquitin activating enzyme
- E2:
-
ubiquitin conjugating enzyme
- E3:
-
ubiquitin ligase
- E4:
-
ubiquitin-chain elongating factor
- HD:
-
Huntington’s disease
- HDAC6:
-
histone deacetylase 6
- LC3:
-
microtubule-associated protein-light chain 3
- LIR:
-
LC3-interacting region
- PB1:
-
protein binding domain1
- PD:
-
Parkinson’s disease
- PE:
-
phosphatidylethanolamine
- p62/SQSTM1:
-
p62/sequestosome1
- Ub:
-
ubiquitin
- UBA:
-
ubiquitin-associating domain
- UBL:
-
ubiquitin-like
- UPP:
-
ubiquitin/proteasome pathway
References
Abeliovich H, Klionsky DJ. 2001. Autophagy in yeast: Mechanistic insights and physiological function. Microbiol Mol Biol Rev 65: 463–479.
Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. 1998. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 21: 516–520.
Bader N, Jung T, Grune T. 2007. The proteasome and its role in nuclear protein maintenance. Exp Gerontol 42: 864–870.
Benaroudj N, Zwickl P, Seemuller E, Baumeister W, Goldberg AL. 2003. ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation. Mol Cell 11: 69–78.
Boland B, Nixon RA. 2006. Neuronal macroautophagy: From development to degeneration. Mol Aspects Med 27: 503–519.
Brooks P, Fuertes G, Murray RZ, Bose S, Knecht E, et al. 2000. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem J 346 (Pt 1): 155–161.
Chen P, Hochstrasser M. 1996. Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell 86: 961–972.
Coux O, Tanaka K, Goldberg AL. 1996. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65: 801–847.
DeMartino GN, Slaughter CA. 1999. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem 274: 22123–22126.
Groll M, Bajorek M, Kohler A, Moroder L, Rubin DM, et al. 2000. A gated channel into the proteasome core particle. Nat Struct Biol 7: 1062–1067.
Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, et al. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386: 463–471.
Gronostajski RM, Pardee AB, Goldberg AL. 1985. The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts. J Biol Chem 260: 3344–3349.
Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, et al. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885–889.
Hartmann-Petersen R, Semple CA, Ponting CP, Hendil KB, Gordon C. 2003. UBA domain containing proteins in fission yeast. Int J Biochem Cell Biol 35: 629–636.
Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem 67: 425–479.
Jenner P. 2003. Oxidative stress in Parkinson’s disease. Ann Neurol 53 (Suppl 3): S26–S36.
Johnson DE. 2000. Noncaspase proteases in apoptosis. Leukemia 14: 1695–1703.
Keller JN, Gee J, Ding Q. 2002. The proteasome in brain aging. Ageing Res Rev 1: 279–293.
Keller JN, Hanni KB, Markesbery WR. 2000. Impaired proteasome function in Alzheimer’s disease. J Neurochem 75: 436–439.
Kirkegaard K, Taylor MP, Jackson WT. 2004. Cellular autophagy: Surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2: 301–314.
Kisselev AF, Akopian TN, Castillo V, Goldberg AL. 1999. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell 4: 395–402.
Klionsky DJ. 2005. The molecular machinery of autophagy: Unanswered questions. J Cell Sci 118: 7–18.
Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, et al. 2006. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880–884.
Larsen KE, Sulzer D. 2002. Autophagy in neurons: A review. Histol Histopathol 17: 897–908.
Lee DH, Goldberg AL. 1998. Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 8: 397–403.
Liu CW, Corboy MJ, DeMartino GN, Thomas PJ. 2003. Endoproteolytic activity of the proteasome. Science 299: 408–411.
Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, et al. 1988. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease, and Alzheimer’s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 155: 9–15.
Madura K. 2004. Rad23 and Rpn10: Perennial wallflowers join the melee. Trends Biochem Sci 29: 637–640.
Massey AC, Zhang C, Cuervo AM. 2006. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 73: 205–235.
McGrath ME. 1999. The lysosomal cysteine proteases. Annu Rev Biophys Biomol Struct 28: 181–204.
McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW. 2003. Altered proteasomal function in sporadic Parkinson’s disease. Exp Neurol 179: 38–46.
Mizushima N, Klionsky DJ. 2007. Protein turnover via autophagy: Implications for metabolism (*). Annu Rev Nutr 27: 19–40.
Mizushima N, Ohsumi Y, Yoshimori T. 2002. Autophagosome formation in mammalian cells. Cell Struct Funct 27: 421–429.
Moore DJ, Dawson VL, Dawson TM. 2003. Role for the ubiquitin-proteasome system in Parkinson’s disease and other neurodegenerative brain amyloidoses. Neuromol Med 4: 95–108.
Ohsumi Y. 2001. Molecular dissection of autophagy: Two ubiquitin-like systems. Nat Rev Mol Cell Biol 2: 211–216.
Orlowski M, Wilk S. 2000. Catalytic activities of the 20S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys 383: 1–16.
Pandey UB, Batlevi Y, Baehrecke EH, Taylor JP. 2007a. HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration. Autophagy 3: 643–645.
Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, et al. 2007b. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447: 859–863.
Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, et al. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131–24145.
Park I, Chung J, Walsh CT, Yun Y, Strominger JL, et al. 1995. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. Proc Natl Acad Sci USA 92: 12338–12342.
Raasi S, Orlov I, Fleming KG, Pickart CM. 2004. Binding of polyubiquitin chains to ubiquitin-associated (UBA) domains of HHR23A. J Mol Biol 341: 1367–1379.
Rape M, Jentsch S. 2004. Productive RUPture: Activation of transcription factors by proteasomal processing. Biochim Biophys Acta 1695: 209–213.
Reggiori F, Klionsky DJ. 2005. Autophagosomes: Biogenesis from scratch? Curr Opin Cell Biol 17: 415–422.
Rubinsztein DC. 2006. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443: 780–786.
Schmidtke G, Kraft R, Kostka S, Henklein P, Frommel C, et al. 1996. Analysis of mammalian 20S proteasome biogenesis: The maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J 15: 6887–6898.
Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, et al. 2004. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24: 8055–8068.
Seo H, Sonntag KC, Isacson O. 2004. Generalized brain and skin proteasome inhibition in Huntington’s disease. Ann Neurol 56: 319–328.
Sharon M, Witt S, Felderer K, Rockel B, Baumeister W, et al. 2006. 20S proteasomes have the potential to keep substrates in store for continual degradation. J Biol Chem 281: 9569–9575.
Sharon M, Witt S, Glasmacher E, Baumeister W, Robinson CV. 2007. Mass spectrometry reveals the missing links in the assembly pathway of the bacterial 20S proteasome. J Biol Chem 282: 18448–18457.
Thrower JS, Hoffman L, Rechsteiner M, Pickart CM. 2000. Recognition of the polyubiquitin proteolytic signal. EMBO J 19: 94–102.
Wang CW, Klionsky DJ. 2003. The molecular mechanism of autophagy. Mol Med 9: 65–76.
Wang R, Chait BT, Wolf I, Kohanski RA, Cardozo C. 1999. Lysozyme degradation by the bovine multicatalytic proteinase complex (proteasome): Evidence for a nonprocessive mode of degradation. Biochemistry 38: 14573–14581.
Wang Z, Figueiredo-Pereira ME. 2005. Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity. Mol Cell Neurosci 29: 222–231.
Wilkinson CR, Seeger M, Hartmann-Petersen R, Stone M, Wallace M, et al. 2001. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol 3: 939–943.
Wilkinson KD. 1999. Ubiquitin-dependent signaling: The role of ubiquitination in the response of cells to their environment. J Nutr 129: 1933–1936.
Wojcik C, DeMartino GN. 2003. Intracellular localization of proteasomes. Int J Biochem Cell Biol 35: 579–589.
Wooten MW, Hu X, Babu JR, Seibenhener ML, Geetha T, et al. 2006. Signaling, polyubiquitination, trafficking, and inclusions: Sequestosome 1/p62’s role in neurodegenerative disease. J Biomed Biotechnol 2006: 62079.
Young P, Deveraux Q, Beal RE, Pickart CM, Rechsteiner M. 1998. Characterization of two polyubiquitin binding sites in the 26S protease subunit 5a. J Biol Chem 273: 5461–5467.
Acknowledgments
Please note that this review is not intended to be comprehensive and we apologize to the authors whose work is not mentioned. This work was supported by NIH [NS41073 (SNRP) to M.E.F.P. (head of sub-project) from NINDS, and RR03037 to Hunter College from NIGMS/RCMI].
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this entry
Cite this entry
Myeku, N., Figueiredo-Pereira, M.E. (2009). Ubiquitin/Proteasome and Autophagy/Lysosome Pathways: Comparison and Role in Neurodegeneration. In: Lajtha, A., Banik, N., Ray, S.K. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30375-8_21
Download citation
DOI: https://doi.org/10.1007/978-0-387-30375-8_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-30343-7
Online ISBN: 978-0-387-30375-8
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences